Degarelix Neo-Adjuvant Radical Prostatectomy Trial

NCT01674270 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Degarelix
DRUG: Casodex
DRUG: LHRH Agonist

Sponsor

University Health Network, Toronto